Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.

Bedi D, Gillespie JW, Petrenko VA. Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Eng Des Sel. 2014 Jul; 27(7):235-43.

View in: PubMed

authors with profiles

Deepa Bedi

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support